Hyzaar DS

Hyzaar DS is a formulation of Hyzaar, combining a higher dose of losartan and hydrochlorothiazide for the effective management of high blood pressure and stroke risk reduction. Developed by Merck, Hyzaar DS is particularly useful for patients requiring a more potent antihypertensive effect. The combination of losartan, an angiotensin II receptor blocker, and hydrochlorothiazide, a diuretic, provides dual action by relaxing blood vessels and reducing fluid retention, leading to improved blood pressure control. Hyzaar DS’s higher dosage strength is designed to meet the needs of patients with more challenging blood pressure management requirements. With a solid safety profile and proven efficacy, Hyzaar DS supports cardiovascular health and helps reduce the risk of complications associated with hypertension.